Breaking through to the Other Side: Microenvironment Contributions to DCIS Initiation and Progression

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Refinements in early detection, surgical and radiation therapy, and hormone receptor-targeted treatments have improved the survival rates for breast cancer patients. However, the ability to reliably identify which non-invasive lesions and localized tumors have the ability to progress and/or metastasize remains a major unmet need in the field. The current diagnostic and therapeutic strategies focus on intrinsic alterations within carcinoma cells that are closely associated with proliferation. However, substantial accumulating evidence has indicated that permissive changes in the stromal tissues surrounding the carcinoma play an integral role in breast cancer tumor initiation and progression. Numerous studies have suggested that the stromal environment surrounding ductal carcinoma in situ (DCIS) lesions actively contributes to enhancing tumor cell invasion and immune escape. This review will describe the current state of knowledge regarding the mechanisms through which the microenvironment interacts with DCIS lesions focusing on recent studies that describe the contributions of myoepithelial cells, fibroblasts and immune cells to invasion and subsequent progression. These mechanisms will be considered in the context of developing biomarkers for identifying lesions that will progress to invasive carcinoma and/or developing approaches for therapeutic intervention.

Original languageEnglish (US)
Pages (from-to)207-221
Number of pages15
JournalJournal of mammary gland biology and neoplasia
Volume23
Issue number4
DOIs
StatePublished - Dec 1 2018

Fingerprint

Carcinoma, Intraductal, Noninfiltrating
Breast Neoplasms
Carcinoma
Secondary Prevention
Neoplasms
Radiotherapy
Therapeutics
Survival Rate
Fibroblasts
Biomarkers
Hormones

Keywords

  • DCIS
  • Ductal carcinoma in situ
  • Fibroblast
  • Immune
  • Mammary gland
  • Myoepithelial
  • Tumor microenvironment

PubMed: MeSH publication types

  • Journal Article
  • Review
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

Cite this

Breaking through to the Other Side : Microenvironment Contributions to DCIS Initiation and Progression. / Nelson, Andrew C; Machado, Heather L.; Schwertfeger, Kaylee.

In: Journal of mammary gland biology and neoplasia, Vol. 23, No. 4, 01.12.2018, p. 207-221.

Research output: Contribution to journalReview article

@article{4a6711770c0a4169a47cf7fdbbe74e16,
title = "Breaking through to the Other Side: Microenvironment Contributions to DCIS Initiation and Progression",
abstract = "Refinements in early detection, surgical and radiation therapy, and hormone receptor-targeted treatments have improved the survival rates for breast cancer patients. However, the ability to reliably identify which non-invasive lesions and localized tumors have the ability to progress and/or metastasize remains a major unmet need in the field. The current diagnostic and therapeutic strategies focus on intrinsic alterations within carcinoma cells that are closely associated with proliferation. However, substantial accumulating evidence has indicated that permissive changes in the stromal tissues surrounding the carcinoma play an integral role in breast cancer tumor initiation and progression. Numerous studies have suggested that the stromal environment surrounding ductal carcinoma in situ (DCIS) lesions actively contributes to enhancing tumor cell invasion and immune escape. This review will describe the current state of knowledge regarding the mechanisms through which the microenvironment interacts with DCIS lesions focusing on recent studies that describe the contributions of myoepithelial cells, fibroblasts and immune cells to invasion and subsequent progression. These mechanisms will be considered in the context of developing biomarkers for identifying lesions that will progress to invasive carcinoma and/or developing approaches for therapeutic intervention.",
keywords = "DCIS, Ductal carcinoma in situ, Fibroblast, Immune, Mammary gland, Myoepithelial, Tumor microenvironment",
author = "Nelson, {Andrew C} and Machado, {Heather L.} and Kaylee Schwertfeger",
year = "2018",
month = "12",
day = "1",
doi = "10.1007/s10911-018-9409-z",
language = "English (US)",
volume = "23",
pages = "207--221",
journal = "Journal of Mammary Gland Biology and Neoplasia",
issn = "1083-3021",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Breaking through to the Other Side

T2 - Microenvironment Contributions to DCIS Initiation and Progression

AU - Nelson, Andrew C

AU - Machado, Heather L.

AU - Schwertfeger, Kaylee

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Refinements in early detection, surgical and radiation therapy, and hormone receptor-targeted treatments have improved the survival rates for breast cancer patients. However, the ability to reliably identify which non-invasive lesions and localized tumors have the ability to progress and/or metastasize remains a major unmet need in the field. The current diagnostic and therapeutic strategies focus on intrinsic alterations within carcinoma cells that are closely associated with proliferation. However, substantial accumulating evidence has indicated that permissive changes in the stromal tissues surrounding the carcinoma play an integral role in breast cancer tumor initiation and progression. Numerous studies have suggested that the stromal environment surrounding ductal carcinoma in situ (DCIS) lesions actively contributes to enhancing tumor cell invasion and immune escape. This review will describe the current state of knowledge regarding the mechanisms through which the microenvironment interacts with DCIS lesions focusing on recent studies that describe the contributions of myoepithelial cells, fibroblasts and immune cells to invasion and subsequent progression. These mechanisms will be considered in the context of developing biomarkers for identifying lesions that will progress to invasive carcinoma and/or developing approaches for therapeutic intervention.

AB - Refinements in early detection, surgical and radiation therapy, and hormone receptor-targeted treatments have improved the survival rates for breast cancer patients. However, the ability to reliably identify which non-invasive lesions and localized tumors have the ability to progress and/or metastasize remains a major unmet need in the field. The current diagnostic and therapeutic strategies focus on intrinsic alterations within carcinoma cells that are closely associated with proliferation. However, substantial accumulating evidence has indicated that permissive changes in the stromal tissues surrounding the carcinoma play an integral role in breast cancer tumor initiation and progression. Numerous studies have suggested that the stromal environment surrounding ductal carcinoma in situ (DCIS) lesions actively contributes to enhancing tumor cell invasion and immune escape. This review will describe the current state of knowledge regarding the mechanisms through which the microenvironment interacts with DCIS lesions focusing on recent studies that describe the contributions of myoepithelial cells, fibroblasts and immune cells to invasion and subsequent progression. These mechanisms will be considered in the context of developing biomarkers for identifying lesions that will progress to invasive carcinoma and/or developing approaches for therapeutic intervention.

KW - DCIS

KW - Ductal carcinoma in situ

KW - Fibroblast

KW - Immune

KW - Mammary gland

KW - Myoepithelial

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85053237485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053237485&partnerID=8YFLogxK

U2 - 10.1007/s10911-018-9409-z

DO - 10.1007/s10911-018-9409-z

M3 - Review article

VL - 23

SP - 207

EP - 221

JO - Journal of Mammary Gland Biology and Neoplasia

JF - Journal of Mammary Gland Biology and Neoplasia

SN - 1083-3021

IS - 4

ER -